Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Intra-Cellular Therapies Waste Data Preview

In 2023, Intra-Cellular Therapies conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Intra-Cellular Therapies's Waste Management data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Intra-Cellular Therapies’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Intra-Cellular Therapies’s data sources below and access millions more through our Disclosure Search.

a. Intra-Cellular Therapies's Sustainability Report 2023
Trace every data point back to Intra-Cellular Therapies’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Intra-Cellular Therapies's Waste Treatment Practices

In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste. a

Of this amount, 20% of Intra-Cellular Therapies's total waste generated was recovered through methods such as recycling, reuse, or composting, while 80% was disposed of through landfilling, incineration, or combustion. a

Intra-Cellular Therapies's Waste Recovery Rate

20%

How much of Intra-Cellular Therapies's waste is recycled or recovered?

In 2023, Intra-Cellular Therapies reported a total waste generation of 2 metric tonnes, of which 20% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Intra-Cellular Therapies may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives. a

Insights into Intra-Cellular Therapies’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste. a

Of this amount, 80% of Intra-Cellular Therapies's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 20% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. a

Want Full Access to Intra-Cellular Therapies's Waste Management Dataset?
Sign Up